Augmentation of intracranial self-stimulation induced by amphetamine-like drugs in Period circadian regulator 2 knockout mice is associated with intracellular Ca2+ levels

• Published in: Neuroscience research
• Main Authors: Kwon, Hyeokjun, Hong, Eunchong, Lee, Yong Sup, Cheong, Jae Hoon, Kim, Hee Jin, Kim, Soyoung, Yun, Jaesuk
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 31.07.2024
• Subjects: Ca2; Intracranial self-stimulation; METH; New psychoactive substances; Period circadian regulator 2; PMMA; METH; Intracranial self-stimulation; New psychoactive substances; PMMA; Period circadian regulator 2; Ca2
• ISSN: 0168-0102; 1872-8111; 1872-8111
• DOI: 10.1016/j.neures.2024.07.007

Over the past decade, new psychoactive substances (NPS) have emerged in the illegal drug market and have continued to attract attention from the international community. Among these, amphetamine-like NPS, classified as stimulants, constitute a significant proportion. However, the pharmacological characteristics and mechanisms underlying addiction to amphetamine-like NPS remain poorly understood. Given that circadian rhythms are linked to the brain stimulation effects of methamphetamine (METH) and amphetamine, we investigated the effects of METH, 1-(4-methoxyphenyl)-N-methylpropan-2-amine (PMMA), and 1-(benzofuran-5-yl)-N-ethylpropan-2-amine (5-EAPB) on intracranial self-stimulation (ICSS) in wild-type (WT) or Period circadian regulator 2 knockout mice. Amphetamine-like drugs increase intracellular Ca2+ levels to provoke dopamine release, so we examined the impact of Per2 knockdown on intracellular Ca2+ levels in PC12 cells to elucidate a potential mechanism underlying NPS-induced ICSS enhancement. Our ICSS results showed that METH and PMMA significantly increased brain stimulation in Per2 knockout mice compared to WT mice. Similarly, METH and PMMA induced higher Ca2+ fluorescence intensity in Per2 knockdown PC12 cells than in control cells. In contrast, 5-EAPB did not produce significant changes in either ICSS or Ca2+ signaling. These findings suggest that Per2 plays a crucial role in the brain stimulation effects of amphetamine-like drugs through the regulation of intracellular Ca2+. •Per2 gene deletion amplifies METH and PMMA-induced brain stimulation.•Calcium signaling alterations observed in Per2 KO mice correlate with increased drug responses.•Novel insights into circadian gene Per2's role in NPS-related neurobiological mechanisms.•ICSS experiments reveal heightened vulnerability to amphetamine-like substances in Per2 KO.•Per2 may be a potential target for understanding and mitigating NPS induced reward-related behaviors.